Matches in SemOpenAlex for { <https://semopenalex.org/work/W4299431190> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- W4299431190 endingPage "11" @default.
- W4299431190 startingPage "11" @default.
- W4299431190 abstract "Abacavir (Ziagen), a nucleoside analogue, is expected to be approved by the FDA for treatment of HIV in adults and children, and be available by the end of the year. Studies indicate abacavir is the most potent of the six approved nucleoside analogues in people who are treatment-naive. Information on dosing and side effects is given. A serious hypersensitivity reaction, occurring in about 3 percent of people, usually resolves within one to two days after discontinuing the drug. Abacavir should not be used again in these people, however, as the subsequent reaction can be fatal." @default.
- W4299431190 created "2022-10-02" @default.
- W4299431190 date "1998-12-01" @default.
- W4299431190 modified "2023-10-18" @default.
- W4299431190 title "Abacavir update." @default.
- W4299431190 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11366488" @default.
- W4299431190 hasPublicationYear "1998" @default.
- W4299431190 type Work @default.
- W4299431190 citedByCount "0" @default.
- W4299431190 crossrefType "journal-article" @default.
- W4299431190 hasConcept C142462285 @default.
- W4299431190 hasConcept C159047783 @default.
- W4299431190 hasConcept C185592680 @default.
- W4299431190 hasConcept C2776543447 @default.
- W4299431190 hasConcept C2777288759 @default.
- W4299431190 hasConcept C2777333352 @default.
- W4299431190 hasConcept C2779465607 @default.
- W4299431190 hasConcept C2993143319 @default.
- W4299431190 hasConcept C3013748606 @default.
- W4299431190 hasConcept C71240020 @default.
- W4299431190 hasConcept C71924100 @default.
- W4299431190 hasConcept C98274493 @default.
- W4299431190 hasConceptScore W4299431190C142462285 @default.
- W4299431190 hasConceptScore W4299431190C159047783 @default.
- W4299431190 hasConceptScore W4299431190C185592680 @default.
- W4299431190 hasConceptScore W4299431190C2776543447 @default.
- W4299431190 hasConceptScore W4299431190C2777288759 @default.
- W4299431190 hasConceptScore W4299431190C2777333352 @default.
- W4299431190 hasConceptScore W4299431190C2779465607 @default.
- W4299431190 hasConceptScore W4299431190C2993143319 @default.
- W4299431190 hasConceptScore W4299431190C3013748606 @default.
- W4299431190 hasConceptScore W4299431190C71240020 @default.
- W4299431190 hasConceptScore W4299431190C71924100 @default.
- W4299431190 hasConceptScore W4299431190C98274493 @default.
- W4299431190 hasIssue "26" @default.
- W4299431190 hasLocation W42994311901 @default.
- W4299431190 hasOpenAccess W4299431190 @default.
- W4299431190 hasPrimaryLocation W42994311901 @default.
- W4299431190 hasRelatedWork W1536891796 @default.
- W4299431190 hasRelatedWork W2003174644 @default.
- W4299431190 hasRelatedWork W2027682514 @default.
- W4299431190 hasRelatedWork W2092029818 @default.
- W4299431190 hasRelatedWork W2114786565 @default.
- W4299431190 hasRelatedWork W2137562741 @default.
- W4299431190 hasRelatedWork W2319277371 @default.
- W4299431190 hasRelatedWork W2409101395 @default.
- W4299431190 hasRelatedWork W4206957532 @default.
- W4299431190 hasRelatedWork W2264360613 @default.
- W4299431190 isParatext "false" @default.
- W4299431190 isRetracted "false" @default.
- W4299431190 workType "article" @default.